Furthermore, a genome-wide CRISPR screen for CD8+ T cell fitness revealed that Roquin-1 depletion promotes T cell expansion and anti-tumor immunity by upregulating IRF4 [158]. The gene discussed is CD8A; the disease is neoplasm.